Status:
WITHDRAWN
Oxygen Saturation: Analytical Comparison for COVID
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Hypoxemia
Covid-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In many patients, respiratory Sars-Cov2 infection causes arterial hypoxemia, which remains without signs of verbalized respiratory distress, up to a point. This phenomenon, called "happy" or "silent" ...
Detailed Description
The constant monitoring of saturation by the pulse oximeter, the result of three centuries of technological progress, has introduced a true revolution in medical management that now relies on this vit...
Eligibility Criteria
Inclusion
- Patients hospitalized in the intensive care unit for COVID
- Age ≥ 18 years
- Patients or family/trusted person informed and not objecting to participating in the research
Exclusion
- Carbon monoxide poisoning
- Homozygous sickle cell disease
- Severe anemia (\< 7 g/L) with associated hypoxemia
- Methemoglobinemia
- Sulfhemoglobinemia
- Sepsis, vasoconstrictive drugs
- Patients under guardianship / curators
- Patient under state medical aid
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 2 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04874805
Start Date
May 2 2022
End Date
May 2 2022
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pneumologie, Médecine Intensive et Réanimation (SPMIR-R3S) Hôpital Pitié-Salpêtrière
Paris, France, 75013